Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1629 of 5804
-
New donor cartilage implant aims to fix knee damage in one surgery
Disease control OngoingThe purpose of this clinical study is to evaluate the use of ProChondrix Cryopreserved Osteochondral Allograft to obtain evidence of effectiveness, defined as an improvement in physical function and pain, when used on a symptomatic cartilage defect on the femoral condyle or patel…
Sponsor: AlloSource • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Vitamin d Mega-Dose tested to fight memory loss in seniors
Disease control OngoingThis Phase II randomized clinical trial aims to test if supplementation with high dose oral vitamin D will successfully correct vitamin D insufficiency, compared to treatment with standard (RDA) dose vitamin D in a diverse community-based elderly cohort. The effect of high-dose v…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a diabetes drug help stop AFib after ablation?
Disease control OngoingThe goal (or purpose) of this study is to evaluate (study) a new way to stabilize (steady) the activity between the fat deposits surrounding the heart and the left atrium. To reduce the amount of EAT, this study will use a medication called Liraglutide. This medication is known …
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Glow-in-the-Dark dye helps surgeons find hidden cancer spots
Diagnosis CompletedThe objective of this feasibility study is to assess the initial safety and efficacy of the LUM Imaging System for in vivo imaging of metastases to the peritoneum from primary gastrointestinal cancer, ovarian cancer and mesothelioma. This feasibility study consists of a dose esca…
Phase: PHASE1, PHASE2 • Sponsor: Lumicell, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Slow drip, less pain: new study aims to prevent chemo nerve damage
Symptom relief Recruiting nowThis phase II trial studies how well giving oxaliplatin over 6 hours works in treating nerve damage in patients with gastrointestinal cancers. Oxaliplatin can cause side effects such as nerve damage that may delay or reduce the dose of oxaliplatin. Giving oxaliplatin over a longe…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Promising combo tackles FLT3 leukemia in early trial
Disease control CompletedThis phase I study hopes to explore how safe and tolerable is the combination of gemtuzumab ozogamicin (GO) and midostaurin, with the standard induction therapy (cytarabine and daunorubicin) in patients with newly diagnosed FLT-3 mutated Acute Myeloid Leukemia (AML). GO is FDA ap…
Phase: PHASE1 • Sponsor: Uma Borate • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New radiation approach targets liver tumors without surgery
Disease control OngoingIntervention research involving the human person, phase II, prospective, multicentric, non-randomized and multi-cohort study. The eligibility criteria are broad, on purpose, so every patient, able to be treated by SBRT and unable to participate in another trial (non eligible pati…
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Engineered immune cells with an emergency brake tested in lymphoma
Disease control OngoingThis research study combines 2 different ways of fighting disease: antibodies and T cells. Both antibodies and T cells have been used to treat patients with cancers, and both have shown promise, but neither alone has been sufficient to cure most patients. This study combines both…
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Chemo before surgery may save eye and skull in sinus cancer patients
Disease control Recruiting nowThis randomized phase II trial studies how well chemotherapy before surgery and radiation therapy works compared to surgery and radiation therapy alone in treating patients with nasal and paranasal sinus cancer that can be removed by surgery. Drugs used in chemotherapy, such as d…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple drug make donated kidneys start working faster?
Disease control TerminatedOrgan shortage for transplant has necessitated use of kidneys from older donors, increasing the chance that the kidney will not work immediately or for as long as expected. The investigators gave the drug heme arginate (HA) to 20 kidney transplant patients in the first 24 hours a…
Phase: PHASE3 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Turmeric compound tested to stop prostate cancer growth
Disease control Recruiting nowThis is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.
Phase: PHASE3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia
Disease control TerminatedVenetoclax and ibrutinib have complementary activity in clearing the disease across anatomical compartments. By combining ibrutinib with venetoclax, cells can be mobilized from tissues into the bloodstream by ibrutinib and killed in the blood by venetoclax. Consistently, the vene…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Gene-Editing hope: could BIVV003 free sickle cell patients from pain crises?
Disease control CompletedThis is an open label, multicenter, Phase 1/2 study in approximately eight adults with severe Sickle Cell Disease (SCD). The study will evaluate the safety, tolerability, and efficacy of autologous hematopoietic stem cell transplantation using BIVV003.
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 15:44 UTC
-
HIV treatment showdown: which combo works best for Late-Stage patients?
Disease control CompletedThe main purpose of this study is to compare two different types of HIV treatments, in terms of effectiveness and improvement of side effects, for patients who are diagnosed with a more advanced HIV infection. Patients with advanced HIV infections are otherwise known as 'late pre…
Phase: PHASE3 • Sponsor: NEAT ID Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Paws for healing: service dog training may soothe PTSD and brain injury symptoms
Symptom relief CompletedPreliminary clinical evidence suggests that Service Members with symptoms of post-traumatic stress disorder (PTSD) or Post Traumatic Stress (PTS) who participate in the Service Dog Training Program (SDTP) report improved physical and psychological outcomes, including those with o…
Phase: NA • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Symptom relief
Last updated Jun 26, 2026 12:54 UTC
-
Can a special drink cut surgery complications in bladder cancer?
Disease control OngoingThis phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New ablation catheter shows promise for treating irregular heartbeat
Disease control CompletedTo obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines. Primary objective: To assess acute and long-term outc…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
App aims to tame asthma in teens
Disease control OngoingThe goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.
Phase: NA • Sponsor: Arkansas Children's Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a shorter steroid course be just as good for HIV-Related pneumonia?
Disease control ENROLLING_BY_INVITATIONThe treatment guidelines for Pneumocystis pneumonia (PCP) suggest adding 40mg of prednisone (or its equivalent in methylprednisolone) twice per day on days 1 through 5, 40 mg days 6 through 10, and 20 mg daily on days 11 through 21 in subjects with moderate and serious PCP. Stero…
Phase: NA • Sponsor: Centro de Investigación en. Enfermedades Infecciosas, Mexico • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Which ventilator mode helps patients breathe on their own sooner?
Disease control Recruiting nowThe objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC